Skip to Main Content

Author Details

Sunita K Agarwal
National Institute of Diabetes and Digestive and Kidney Diseases
1993
100
42
PMIDPaper TitleJournal TitlePublished Year
37307230Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.J Clin Endocrinol Metab2023
37284613Long-Term Outcomes of Parathyroid Autografts in Primary Hyperparathyroidism.J Endocr Soc2023
37339334Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.J Clin Endocrinol Metab2023
37307230Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.J Clin Endocrinol Metab2023
37284613Long-Term Outcomes of Parathyroid Autografts in Primary Hyperparathyroidism.J Endocr Soc2023
37339334Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.J Clin Endocrinol Metab2023
36111275Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors.J Endocr Soc2022
36111275Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors.J Endocr Soc2022
35861986Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.Eur J Endocrinol2022
37283960Mice With RIP-Cre-mediated Deletion of the Long Noncoding RNA <i>Meg3</i> Show Normal Pancreatic Islets and Enlarged Pituitary.J Endocr Soc2022
35861986Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.Eur J Endocrinol2022
37283960Mice With RIP-Cre-mediated Deletion of the Long Noncoding RNA <i>Meg3</i> Show Normal Pancreatic Islets and Enlarged Pituitary.J Endocr Soc2022
32756962Patients With MEN1 Are at an Increased Risk for Venous Thromboembolism.J Clin Endocrinol Metab2021
33537001Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors.Front Endocrinol (Lausanne)2021
34318891A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.J Clin Endocrinol Metab2021
33249439Multiple Endocrine Neoplasia Type 1: Latest Insights.Endocr Rev2021
32756962Patients With MEN1 Are at an Increased Risk for Venous Thromboembolism.J Clin Endocrinol Metab2021
34515662Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus.Endocr Relat Cancer2021
34788508Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.N Engl J Med2021
33537001Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors.Front Endocrinol (Lausanne)2021
34788508Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.N Engl J Med2021
34515662Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus.Endocr Relat Cancer2021
34318891A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.J Clin Endocrinol Metab2021
33249439Multiple Endocrine Neoplasia Type 1: Latest Insights.Endocr Rev2021
3213020018F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma.Endocrinol Diabetes Metab Case Rep2020
3213020018F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma.Endocrinol Diabetes Metab Case Rep2020
32384260c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs.J Mol Endocrinol2020
32706863Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.J Clin Endocrinol Metab2020
32706863Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.J Clin Endocrinol Metab2020
32384260c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs.J Mol Endocrinol2020
31480016Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1.Endocrinol Diabetes Metab Case Rep2019
31480016Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1.Endocrinol Diabetes Metab Case Rep2019
29149451Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.Cancer2018
29309627Functional Defects From Endocrine Disease-Associated Mutations in HLXB9 and Its Interacting Partner, NONO.Endocrinology2018
29615472Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.J Mol Endocrinol2018
29467239Frequency and consequence of the recurrent <i>YY1</i> p.T372R mutation in sporadic insulinomas.Endocr Relat Cancer2018
29691295Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>.Clin Cancer Res2018
29149451Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.Cancer2018
29108698Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.Surgery2018
29408534Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.J Am Coll Surg2018
29615472Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.J Mol Endocrinol2018
29467239Frequency and consequence of the recurrent <i>YY1</i> p.T372R mutation in sporadic insulinomas.Endocr Relat Cancer2018
29691295Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>.Clin Cancer Res2018
29408534Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.J Am Coll Surg2018
29309627Functional Defects From Endocrine Disease-Associated Mutations in HLXB9 and Its Interacting Partner, NONO.Endocrinology2018
29108698Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.Surgery2018
28847847Long Noncoding RNA MEG3 Is an Epigenetic Determinant of Oncogenic Signaling in Functional Pancreatic Neuroendocrine Tumor Cells.Mol Cell Biol2017
28899949The future: genetics advances in MEN1 therapeutic approaches and management strategies.Endocr Relat Cancer2017
28847847Long Noncoding RNA MEG3 Is an Epigenetic Determinant of Oncogenic Signaling in Functional Pancreatic Neuroendocrine Tumor Cells.Mol Cell Biol2017
29264504Ethnicity of Patients With Germline <i>GCM2</i>-Activating Variants and Primary Hyperparathyroidism.J Endocr Soc2017
  • 1 - 50 of 200

Recommended Authors

Center for Cancer Research, National Cancer Institute Bethesda
Career Start Year 2010
Number of shared co-authors 10
Texas Children's Hospital and Baylor College of Medicine
Career Start Year 2004
Number of shared co-authors 0
Clinical Genetics Branch, National Cancer Institute
Career Start Year 2003
Number of shared co-authors 8
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Career Start Year 2002
Number of shared co-authors 1
The Ohio State University
Career Start Year 2000
Number of shared co-authors 3
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 0
Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 0
Division of Clinical Research, Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 11
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 8
Nova Scotia Health Authority
Career Start Year 1992
Number of shared co-authors 0
Wellcome Trust Sanger Institute
Career Start Year 1992
Number of shared co-authors 0
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 1
University of Texas Health San Antonio
Career Start Year 1990
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1989
Number of shared co-authors 8
Yale School of Medicine
Career Start Year 1989
Number of shared co-authors 3
Intractable Disease Research Center, Graduate School of Medicine, Juntendo University
Career Start Year 1989
Number of shared co-authors 1
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 1
Institute of Human Genetics, University Hospital Magdeburg
Career Start Year 1985
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 2
University of Texas Health San Antonio
Career Start Year 1984
Number of shared co-authors 0
The University of Texas M. D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center Houston
Career Start Year 1983
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 4
Invitae Corporation
Career Start Year 1976
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 5
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 1
Segal Cancer Centre, Jewish General Hospital
Career Start Year 1962
Number of shared co-authors 4

Collaborators

National Institutes of Digestive Disease and Kidney, National Institutes of Health
Co-authored papers 58
Albert Einstein College of Medicine
Co-authored papers 35
University of Michigan ann arbor
Co-authored papers 34
National Institutes of Health
Co-authored papers 34
Co-authored papers 25
The Francis Crick Institute
Co-authored papers 17
National Cancer Institute, National Institutes of Health
Co-authored papers 15
National Cancer Institute, National Institutes of Health
Co-authored papers 15
Co-authored papers 14
Stanford University School of Medicine
Co-authored papers 12
Center for Cancer Research
Co-authored papers 11
National Cancer Institute, National Institutes of Health
Co-authored papers 7
Precision Medicine Network Inc.
Co-authored papers 4
Case Western Reserve University School of Medicine
Co-authored papers 4
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
National Institutes of Health
Co-authored papers 2
Indiana University School of Medicine
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Chongqing Center for Disease Control and Prevention.
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
The University of Texas at Austin
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Center for Precision Health Research, National Human Genome Research Institute
Co-authored papers 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Co-authored papers 2
Rhode Island Hospital
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2